T CELL LYMPHOBLASTIC LYMPHOMA
Clinical trials for T CELL LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T CELL LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for T CELL LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on tough T-Cell cancers in early trial
Disease control Recruiting nowThis early-phase trial is testing whether a new type of CAR T-cell therapy, made from a patient's own blood cells, is safe for children and adults with T-cell leukemia or lymphoma that has come back or not responded to standard treatments. The therapy targets a protein called CCR…
Matched conditions: T CELL LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: University College, London • Aim: Disease control
Last updated May 26, 2026 04:34 UTC
-
New hope for young patients with hard-to-treat blood cancers
Disease control Recruiting nowThis study tests whether a combination of three drugs (calaspargase pegol-mknl, decitabine, and venetoclax) can help control relapsed or treatment-resistant T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in children, teens, and young adults up to age 21. Th…
Matched conditions: T CELL LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
New trial aims to boost survival in kids with rare lymphoma
Disease control Recruiting nowThis study tests which of two chemotherapy methods works better for children newly diagnosed with T-cell lymphoblastic lymphoma, a rare cancer. About 200 children will receive either high-dose methotrexate or a different escalating dose, both combined with standard drugs. The goa…
Matched conditions: T CELL LYMPHOBLASTIC LYMPHOMA
Phase: PHASE3 • Sponsor: Children's Cancer Group, China • Aim: Disease control
Last updated May 13, 2026 16:01 UTC